FTC sues big pharmacy reward administrators over insulin selling prices The company introduced motion against Caremark, Specific Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating methods “artificially inflated” the listing cost of lifetime-conserving insulin medicines. This strategy aligns with People endeavours, the ONC claimed. The business is tackling https://hectorhxong.blogscribble.com/30717756/rumored-buzz-on-healthcare-news